We’re pleased to announce the availability of administrative supplements to the Institutional Development Awards (IDeA). We invite eligible investigators to submit proposals in response to the following notices:

We’re pleased to announce the availability of supplements to active INBRE (P20), COBRE (P20, P30), IDeA-CTR (U54), and NARCH (S06) awards to support vaccine hesitancy research relevant to SARS-CoV-2. The supplements are aimed at studying the causes of SARS-CoV-2 vaccine hesitancy in IDeA states and/or American Indian/Alaska Native communities, and at developing innovative evidence-based interventions to enhance vaccine acceptance with the goal of increased vaccine uptake.

Applications are due by April 30, 2021; see NOT-GM-21-021 for additional details.

If you have any questions about this supplement opportunity, please contact me.

We’re pleased to announce the availability of supplements to active INBRE (P20), COBRE (P20, P30), IDeA-CTR (U54), and NARCH (S06) awards for sequencing-based surveillance studies of the SARS-CoV-2 virus to track variants circulating in communities the IDeA and NARCH programs serve. The supplements will support SARS-CoV-2 viral genome sequencing and analysis studies. Projects are expected to expand on or collaborate with ongoing SARS-CoV-2 testing studies or programs in order to leverage resources and deliver results quickly to help address the urgent challenge.

Applications are due by March 31, 2021; see NOT-GM-21-031 for additional details.

If you have any questions about this supplement opportunity, please contact me.

UPDATE: The video from this webinar is now available.

We were unable to get together in person for this year’s Native American Research Centers for Health (NARCH) program meeting. Instead, we’re hosting a virtual meeting for NARCH investigators, project directors, and community leaders:

Friday, December 11, 1:30-5:45 p.m. ET

In September, we hosted a virtual meeting for investigators and students supported by the Institutional Development Award (IDeA) program to introduce them to strategic initiatives from NIH leaders in response to COVID-19, and to highlight scientific progress by IDeA researchers. We were pleased with the overwhelming response from the IDeA community—there were approximately 750 attendees and more than 180 abstracts submitted.

We were unable to get together for this year’s National IDeA Symposium of Biomedical Research Excellence. In response to requests from the community, we’re hosting a virtual meeting for investigators and program leaders supported by the Institutional Development Award (IDeA) program:

Tuesday, September 22, 2:00-5:30 p.m. ET

We’d like to call your attention to a pair of recently published notices (NOT-GM-20-042 and NOT-GM-20-043) that address the unfavorable impact of the COVID-19 pandemic on institutions’ ability to recruit faculty investigators. In response to this, we’ve reduced the minimum number of research projects required for our Centers of Biomedical Research Excellence (COBRE) Phases 1 and 2 from three to two. Additionally, we’ll allow budget increases for recruitment costs and pilot projects. These changes apply to active awards and to applications submitted for new Phase 1 (PAR-19-313) and Phase 2 (PAR-19-312) funding opportunity announcements.

I’m pleased to announce that the Institutional Development Award Networks for Clinical and Translational Research (IDeA-CTR) funding opportunity announcement (PAR-20-175) has been reissued.

IDeA-CTR funds statewide or multistate regional networks that support:

We’re pleased to announce that the Native American Research Centers for Health (NARCH) funding opportunity announcement (FOA) (PAR-20-125) has been issued.

NARCH fosters opportunities for biomedical research and career enrichment to meet health needs prioritized by American Indian/Alaska Native (AI/AN) tribes and tribally based organizations. The NARCH initiative also supports research capacity building, including the development of research infrastructure to enhance the biomedical research capabilities of AI/AN communities. NARCH grants are awarded directly to federally recognized tribes or tribal organizations that may partner with research-intensive institutions.

We’re pleased to announce that the Centers of Biomedical Research Excellence (COBRE) Phase 3 funding opportunity announcement (FOA) (PAR-20-115) has been reissued.

COBRE supports thematic, multidisciplinary research centers that establish and strengthen institutional biomedical research capacity in IDeA-eligible states through three sequential 5-year phases.